Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2200018	注射用Belantamab mafodotin	belantamab mafodotin	Lyophilized	Biological Products(2.2)	Import Drug Application	2022-02-17					view
JXSB2101080	Belantamab mafodotin	belantamab mafodotin	Lyophilized	Biological Products(1)	Supplementary Application	2021-11-05					view
JXSB2101043	注射用Belantamab mafodotin	belantamab mafodotin	Lyophilized	Biological Products	Supplementary Application	2021-08-09					view
JXSB2101013	Belantamab mafodotin	belantamab mafodotin	Lyophilized	Biological Products(1)	Supplementary Application	2021-05-24					view
JXSL2000040	Belantamab mafodotin	belantamab mafodotin	Lyophilized	Biological Products	Import Drug Application	2020-04-30	艾昆纬医药科技（上海）有限公司	Aikunwei Medical Technology (Shanghai) Co Ltd	In Review	2020-04-27	view
JXSL2000028	注射用Belantamab mafodotin	belantamab mafodotin	Lyophilized	Biological Products	Import Drug Application	2020-03-19	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2020-03-18	view